Cormorant Global Healthcare Master Fund, LP
Related Filers (57)
- Chen Bihua (88)
- Cormorant Asset Management, LP (88)
- Cormorant Private Healthcare Fund III LP (40)
- Cormorant Private Healthcare Fund II, LP (27)
- Cormorant Global Healthcare GP, LLC (15)
- PROTEOSTASIS THERAPEUTICS, INC. (10)
- CORMORANT PRIVATE HEALTHCARE FUND I, LP (8)
- Biomea Fusion, Inc. (8)
- Erasca, Inc. (6)
- Rain Oncology Inc. (5)
- Ambrx Biopharma Inc. (5)
- EyePoint Pharmaceuticals, Inc. (5)
- Cormorant Private Healthcare Fund IV LP (4)
- Corbus Pharmaceuticals Holdings, Inc. (4)
- ARDELYX, INC. (3)
- Minerva Neurosciences, Inc. (3)
- Axonics Modulation Technologies, Inc. (3)
- Prometheus Biosciences, Inc. (3)
- Edgewise Therapeutics, Inc. (3)
- Immuneering Corp (3)
- GreenLight Biosciences Holdings, PBC (3)
- Akari Therapeutics Plc (2)
- Quotient Ltd (2)
- Sorrento Therapeutics, Inc. (2)
- EAGLE PHARMACEUTICALS, INC. (2)
- HERON THERAPEUTICS, INC. /DE/ (2)
- Recro Pharma, Inc. (2)
- OMEROS CORP (2)
- Apellis Pharmaceuticals, Inc. (2)
- Kiniksa Pharmaceuticals, Ltd. (2)
- Kezar Life Sciences, Inc. (2)
- CONSTELLATION PHARMACEUTICALS INC (2)
- Avidity Biosciences, Inc. (2)
- Akouos, Inc. (2)
- Olema Pharmaceuticals, Inc. (2)
- BioAtla, Inc. (2)
- Design Therapeutics, Inc. (2)
- Verve Therapeutics, Inc. (2)
- Monte Rosa Therapeutics, Inc. (2)
- Elevation Oncology, Inc. (2)
- Aerovate Therapeutics, Inc. (2)
- Icosavax, Inc. (2)
- Tyra Biosciences, Inc. (2)
- Pyxis Oncology, Inc. (2)
- Ventyx Biosciences, Inc. (2)
- Vigil Neuroscience, Inc. (2)
- MoonLake Immunotherapeutics (2)
- Cellectar Biosciences, Inc. (1)
- Intec Pharma Ltd. (1)
- Aptose Biosciences Inc. (1)
- GENVEC INC (1)
- Zynerba Pharmaceuticals, Inc. (1)
- Vitae Pharmaceuticals, Inc (1)
- Clearside Biomedical, Inc. (1)
- Atea Pharmaceuticals, Inc. (1)
- Praxis Precision Medicines, Inc. (1)
- Ambrx Biopharma, Inc. (1)
- Show More ...
Ownership (126)
4
Tuesday, 2/6/2024
Corbus Pharmaceuticals Holdings, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/5/2024
Corbus Pharmaceuticals Holdings, Inc.: Major Shareholders
4
Tuesday, 1/30/2024
Corbus Pharmaceuticals Holdings, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/30/2024
Corbus Pharmaceuticals Holdings, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/11/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/6/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/6/2023
EyePoint Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/25/2023
Ambrx Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/19/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/24/2023
GreenLight Biosciences Holdings, PBC: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 7/3/2023
Praxis Precision Medicines, Inc.: Major Shareholders
4
Monday, 6/26/2023
Erasca, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/8/2023
GreenLight Biosciences Holdings, PBC: Initial statement of beneficial ownership of securities
SC 13D
Thursday, 6/8/2023
GreenLight Biosciences Holdings, PBC: Major Shareholders
SC 13G/A
Monday, 5/1/2023
EyePoint Pharmaceuticals, Inc.: Major Shareholders
3
Monday, 4/24/2023
Immuneering Corp: Initial statement of beneficial ownership of securities
4
Thursday, 4/20/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/17/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 4/3/2023
Biomea Fusion, Inc.: Major Shareholders
4
Thursday, 3/16/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 3/13/2023
Ambrx Biopharma Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Edgewise Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Rain Oncology Inc.: Major Shareholders
4/A
Wednesday, 12/21/2022
Erasca, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
Erasca, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Rain Therapeutics Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Edgewise Therapeutics, Inc.: Major Shareholders
4
Thursday, 1/13/2022
Vigil Neuroscience, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/6/2022
Vigil Neuroscience, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/27/2021
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/20/2021
Ventyx Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 10/15/2021
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/7/2021
Pyxis Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/21/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
Tyra Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/5/2021
Immuneering Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/4/2021
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Immuneering Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 7/28/2021
Icosavax, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/22/2021
Erasca, Inc.: Statement of changes in beneficial ownership of securities
3/A
Friday, 7/16/2021
Erasca, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 7/15/2021
Erasca, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/7/2021
Aerovate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/1/2021
Elevation Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/29/2021
Aerovate Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 6/24/2021
Elevation Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Verve Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/16/2021
Verve Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 5/18/2021
Edgewise Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 5/7/2021
Rain Therapeutics Inc.: Major Shareholders
SC 13D
Friday, 4/30/2021
Biomea Fusion, Inc.: Major Shareholders
4
Thursday, 4/29/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/22/2021
Rain Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/22/2021
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/19/2021
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/15/2021
Biomea Fusion, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/1/2021
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Design Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3/A
Thursday, 3/18/2021
Prometheus Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 3/18/2021
Prometheus Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/11/2021
Prometheus Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 12/22/2020
BioAtla, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/15/2020
BioAtla, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/23/2020
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/18/2020
Olema Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/5/2020
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
Akouos, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/25/2020
Akouos, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/18/2020
Avidity Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/11/2020
Avidity Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 11/2/2018
Axonics Modulation Technologies, Inc.: Statement of changes in beneficial ownership of securities
3/A
Friday, 11/2/2018
Axonics Modulation Technologies, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 10/30/2018
Axonics Modulation Technologies, Inc.: Initial statement of beneficial ownership of securities
3/A
Friday, 7/20/2018
CONSTELLATION PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Wednesday, 7/18/2018
CONSTELLATION PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Wednesday, 6/27/2018
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Kezar Life Sciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/31/2018
Kiniksa Pharmaceuticals, Ltd.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/23/2018
Kiniksa Pharmaceuticals, Ltd.: Initial statement of beneficial ownership of securities
4
Monday, 12/18/2017
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/14/2017
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/8/2017
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 11/7/2017
OMEROS CORP: Major Shareholders
SC 13G/A
Friday, 2/3/2017
Minerva Neurosciences, Inc.: Major Shareholders
4
Wednesday, 12/14/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 12/9/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/6/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/1/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/23/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 11/7/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 11/7/2016
PROTEOSTASIS THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities